MARKET

GNMK

GNMK

GenMark
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.37
+0.03
+0.56%
Opening 12:06 01/27 EST
OPEN
5.26
PREV CLOSE
5.34
HIGH
5.40
LOW
5.20
VOLUME
70.92K
TURNOVER
--
52 WEEK HIGH
8.37
52 WEEK LOW
4.470
MARKET CAP
311.89M
P/E (TTM)
-6.2822
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GNMK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GNMK News

  • The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
  • Benzinga.01/15 13:22
  • GenMark Diagnostics reports 2019 operational and financial outlook
  • Seeking Alpha - Article.01/13 14:40
  • GenMark Diagnostics Sees Q4 Sales $27M vs $27.6M Est
  • Benzinga.01/13 12:09
  • GenMark Diagnostics Narrows FY2019 Sales Guidance from $85M-90M to $88M vs $88.3M Est
  • Benzinga.01/13 12:08

More

Industry

Advanced Medical Equipment & Technology
-1.53%
Healthcare Equipment & Supplies
-0.73%

Hot Stocks

Name
Price
%Change

About GNMK

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.
More

Webull offers GenMark Diagnostics, Inc (GNMK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.